EUCTR2016-002096-96-NL进行中（未招募）1 期
TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia, a multicenter, open-label, non-randomized, controlled study (TOPIC-3 study)
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •- de novo CIN2 or CIN3 lesion, histologically confirmed by diagnostic biopsy
- •- age of 18 years or older
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 140
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- previous histologically confirmed high-grade CIN (CIN 2–3)
- •- concomitant vulvar and/or vaginal intraepithelial neoplasia
- •- previous cervical malignancy
- •- current malignant disease
- •- immunodeficiency (including HIV/AIDS and immunodepressive medication)
- •- pregnancy or lactation
- •- legal incapability
研究者
相似试验
进行中（未招募）
1 期
Imiquimod treatment of premalignant lesions of the uterine cervix.High grade cervical intraepithelial neoplasia.EUCTR2013-001260-34-NLMaastricht University Medical Center210
已完成
不适用
TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia, a multicenter, open-label, non-randomized, controlled study (TOPIC-3 study)NL-OMON47108Medisch Universitair Ziekenhuis Maastricht123
Unknown
不适用
Imiquimod Treatment of High-grade CINCervical Intraepithelial NeoplasiaNCT02917746Maastricht University Medical Center120
终止
3 期
Imiquimod Treatment of CIN LesionsCervical Intraepithelial NeoplasiaNCT02329171Maastricht University Medical Center9
已完成
2 期
ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-TrialCervical Intraepithelial NeoplasiaNCT00941252Medical University of Vienna60